Tech Company Financing Transactions
Cerevast Therapeutics Funding Round
On 12/13/2011, Cerevast Therapeutics received $6.6 million in Series C financing from private investors.
Transaction Overview
Company Name
Announced On
12/13/2011
Transaction Type
Venture Equity
Amount
$6,564,658
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12100 NE 195th St. 150
Bothell, WA 98011
USA
Bothell, WA 98011
USA
Phone
Website
Email Address
Overview
Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradford Zakes
Chief Financial Officer
Kendall Stever
Chief Technical Officer
Francesco Curra
Vice President
Andrew Leo
VP - Bus. Development
Travis Rothlisberger
Browse more venture capital transactions:
Prev: 12/13/2011: Style for Hire venture capital transaction
Next: 12/13/2011: Party Earth venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs